Skip to main content

PRIMECAP MANAGEMENT CO/CA/

Position in NBIX — Neurocrine Biosciences Inc

CIK 763212 PASADENA, CA

Position in NBIX

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$65,387,831
-$6,624,933 QoQ
Shares Held
496,340
-2.2% QoQ
Ownership
0.494%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 96.71193133738969.ToString("F0")% Shared 0.ToString("F0")% None 3.288068662610307.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PRIMECAP MANAGEMENT CO/CA/ holds $1,252,175,954 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
496,340 $65,387,831

All Filings in NBIX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $65,387,831 496,340
2025-12-31 $72,012,764 507,740
2025-09-30 $71,911,058 512,260
2025-06-30 $65,866,587 524,040
2025-03-31 $42,297,864 382,440
2024-12-31 $53,741,415 393,710
2024-09-30 $46,548,880 404,000
2024-06-30 $56,346,954 409,290
2024-03-31 $55,082,489 399,380
2023-12-31 $52,483,038 398,323
2023-09-30 $44,053,312 391,585
2023-06-30 $37,093,848 393,360
2023-03-31 $37,627,522 371,740
2022-12-31 $609,144 5,100